Paper779596
The functions of the macrophage in malignant disease.
Alexander P. Annu Rev Med, 1976. Cited by 132 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The functions of the macrophage in malignant disease. Papers, record 779596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/779596
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macrophages | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| Ascitic Fluid | |
| Cytotoxicity Tests, Immunologic | |
| Humans | |
| Hypersensitivity, Delayed | |
| Immunity, Cellular | |
| Immunotherapy | |
| Lymphocyte Activation | |
| Lymphocytes | |
| Neoplasm Metastasis | |
| Neoplasms, Experimental | |
| Peritoneal Cavity |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11,091,527 | Breast Cancer: A Revolutionary Concept. | Breast Cancer | 1995 | https://conductscience.org/library/papers/11091527 | PubMed |
| 11,089,888 | Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages. | Clin Exp Metastasis | 1999 | https://conductscience.org/library/papers/11089888 | PubMed |
| 9,062,385 | Enhancement of lung-colonizing potential of murine tumor cell lines co-cultivated with activated macrophages. | Clin Exp Metastasis | 1997 | https://conductscience.org/library/papers/9062385 | PubMed |
| 7,283,468 | Ultrastructural studies of spontaneously regressing plane warts. Macrophages attack verruca-epidermal cells. | Arch Dermatol Res | 1981 | https://conductscience.org/library/papers/7283468 | PubMed |
| 7,236,491 | Effects of the Landschütz ascites carcinoma and ascitic fluid on macrophage activity in C. parvum-injected mice. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7236491 | PubMed |
| 7,236,489 | Macrophage content and colony-forming potential in mouse mammary carcinomas. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7236489 | PubMed |
| 7,216,236 | Surveillance of human mitral valve cells by autochthonous lymphocytes, in vitro. | In Vitro | 1980 | https://conductscience.org/library/papers/7216236 | PubMed |
| 7,141,697 | Physicochemical characterization of cytostatic factors released from human monocytes. | Infect Immun | 1982 | https://conductscience.org/library/papers/7141697 | PubMed |
| 7,026,615 | Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7026615 | PubMed |
| 7,020,378 | Carrageenan: a review of its effects on the immune system. | Agents Actions | 1981 | https://conductscience.org/library/papers/7020378 | PubMed |
| 6,978,966 | Logistics of tumor immunology. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/6978966 | PubMed |
| 6,860,547 | Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6860547 | PubMed |
| 6,807,941 | Stimulated murine peritoneal macrophages in suspension and cell culture: enzyme determinations by biochemical and histochemical means. | Histochem J | 1982 | https://conductscience.org/library/papers/6807941 | PubMed |
| 6,607,103 | Differences in the metastatic potential of two sublines of tumor 3LL selected for resistance to natural NK-like effector cells. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6607103 | PubMed |
| 6,543,694 | Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine. | Clin Exp Metastasis | 1984 | https://conductscience.org/library/papers/6543694 | PubMed |
| 6,389,368 | Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea. | Infect Immun | 1984 | https://conductscience.org/library/papers/6389368 | PubMed |
| 6,228,358 | Defective chemotactic factor-induced monocyte complement receptor enhancement in lung cancer. | Clin Exp Immunol | 1983 | https://conductscience.org/library/papers/6228358 | PubMed |
| 4,042,460 | Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity. | Clin Exp Metastasis | 1985 | https://conductscience.org/library/papers/4042460 | PubMed |
| 3,583,069 | Tumour related inhibition of macrophage chemotaxis in patients with colon cancer. | Gut | 1987 | https://conductscience.org/library/papers/3583069 | PubMed |
| 3,490,307 | Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3490307 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/779596
GET https://conductscience.org/api/papers/v1/779596/cited_by?page=2